Abbott Laboratories Drops On Competition For Thyroid Medication - Trading Markets (press release)
Shares closed at $56.80, down $1.30 on the day. Generic drug maker Mylan said Friday it will be allowed to sell a generic version of Abbott's Synthroid drug.